Product Information
SOLU-CORTEF 250 MG ACT-O-VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $51.4321 per EA under NDC 00009001305. Its NADAC has been published 92 times since Nov 20, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
250 mg/2mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009001305
Classification
Brand
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
7/1/2026
Active Ingredients
HYDROCORTISONE SODIUM SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA009866FDA Approved
Before 1982
TE Code
AP
On Market Since
4/27/1955
Pharmacological Classes
Price Statistics
The NADAC for SOLU-CORTEF 250 MG ACT-O-VIAL has been published 92 times since Nov 20, 2024, and over the history we have for it it has risen 35.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $51.4321 per EA |
|---|---|
| All-time high | $51.4321 (Aug 19, 2026) |
| All-time low | $37.9160 (Nov 20, 2024) |
| 52-week high | $51.4321 |
| 52-week low | $42.5939 |
| Median price | $42.5939 |
| Average price | $44.3932 |
| Largest weekly change | +15.0% (Dec 31, 2025) |
| Weeks tracked | 92 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SOLU-CORTEF 250 MG ACT-O-VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SOLU-CORTEF 250 MG ACT-O-VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $51.4321 per EA (NDC 00009001305), effective Aug 19, 2026.
How has the price of SOLU-CORTEF 250 MG ACT-O-VIAL changed over time?
Over the history we have for it, the NADAC for SOLU-CORTEF 250 MG ACT-O-VIAL has risen 35.6%. It has been tracked across 92 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for SOLU-CORTEF 250 MG ACT-O-VIAL?
Since Nov 20, 2024, the NADAC for SOLU-CORTEF 250 MG ACT-O-VIAL has ranged from a low of $37.9160 (Nov 20, 2024) to a high of $51.4321 (Aug 19, 2026), with a median of $42.5939 per EA.
Are there cheaper alternatives to SOLU-CORTEF 250 MG ACT-O-VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SOLU-CORTEF 250 MG ACT-O-VIAL, is $37.9160 per EA — about 26% below SOLU-CORTEF 250 MG ACT-O-VIAL.
Who manufactures SOLU-CORTEF 250 MG ACT-O-VIAL?
SOLU-CORTEF 250 MG ACT-O-VIAL (NDC 00009001305) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.